Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vomiting 1Uterine Cervical Neoplasms 1

Interventions

Cisplatin 6Carboplatin 3spartalizumab 2Paclitaxel 2Drug Therapy 2Bevacizumab 2pembrolizumab 1netupitant, palosentron drug combination 1lenvatinib 1cyclopropapyrroloindole 1camrelizumab 1Vaccines, Synthetic 1Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Metronidazole 1Injections 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Docetaxel 1Dexamethasone 1Control Groups 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Uterine Cervical Neoplasms × netupitant, palosentron drug combination × Clear all
NCT03668639 2021-12-14

Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin

Odense University Hospital

Phase 2/3 Unknown
80 enrolled
Gynecologic

Uterine Cervical Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡